Phase II Study of Gemcitabine Versus S-1 Adjuvant Therapy After Hemihepatectomy for Biliary Tract Cancer
Clinical trial NCT01815307 · COMPLETED
Trial details
- NCT number
- NCT01815307
- Sponsor
- Kansai Hepatobiliary Oncology Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-01
- Primary completion
- 2016-05-01
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.